Framework for verifying elimination of measles and rubella.

Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas.

In the region of the Americas, goals for the elimination of endemic measles and rubella/congenital rubella syndrome (CRS) by the year 2000 and 2010, respectively were established. The successful implementation of measles elimination strategies in the region of the Americas resulted in the interruption of endemic measles transmission in 2002 and tremendous progress toward rubella and CRS elimina...

Global measles and rubella laboratory network support for elimination goals, 2010–2015.

In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan (GVAP)* with the objective to eliminate measles and rubella in five World Health Organization (WHO) regions by 2020. In September 2013, countries in all six WHO regions had established measles elimination goals, and additional goals for elimination of rubella and congenital rubella syndrome were established in three regi...

Use of human diploid cell MRC - 5, for production of Measles and Rubella virus vaccines

Evaluation of Immunity against Rubella and Measles Nine Years after Mass Vaccination Program in Babol Medical Students in Iran

Abstract Background and Aims: Medical students are exposed to various infectious diseases during their clinical training period, including measles and rubella. In Iran, to control the outbreaks of measles and rubella a mass vaccination campaign was conducted on 2003. The present investigation evaluates Immunity to measles and rubella in a group of Babol medical students and determines the ...

The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009–2014

In Canada, measles was eliminated in 1998 and rubella in 2000. Effective measles and rubella surveillance is vital in elimination settings, hinging on reliable laboratory methods. However, low-prevalence settings affect the predictive value of laboratory tests. We conducted an analysis to determine the performance of measles and rubella IgM testing in a jurisdiction where both infections are el...